Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulatory Effects Mediated by Dopamine
Rodrigo Arreola, Samantha Álvarez-Herrera, Gilberto Pérez‐Sánchez, et al.
Journal of Immunology Research (2016) Vol. 2016, pp. 1-31
Open Access | Times Cited: 121

Showing 1-25 of 121 citing articles:

Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease
Stephanie Matt, Peter J. Gaskill
Journal of Neuroimmune Pharmacology (2019) Vol. 15, Iss. 1, pp. 114-164
Open Access | Times Cited: 215
Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
Andrew J. Haak, Enis Kostallari, Delphine Sicard, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 516
Open Access | Times Cited: 178
Dopamine, Immunity, and Disease
Breana Channer, Stephanie Matt, Emily Nickoloff-Bybel, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 62-158
Open Access | Times Cited: 156
Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine
Silvia Capellino, Maren Claus, Carsten Watzl
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 7, pp. 705-711
Open Access | Times Cited: 95
Dopamine: an immune transmitter
Alessandro Castorina, Sarah Thomas Broome, Krystal Louangaphay, et al.
Neural Regeneration Research (2020) Vol. 15, Iss. 12, pp. 2173-2173
Open Access | Times Cited: 90
Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures
Antonio Dominguez‐Meijide, Ana I. Rodríguez‐Pérez, Carmen Díaz-Ruiz, et al.
Brain Behavior and Immunity (2017) Vol. 62, pp. 277-290
Closed Access | Times Cited: 89
Neuroimmune mechanisms of psychostimulant and opioid use disorders
Rebecca S. Hofford, Scott J. Russo, Drew D. Kiraly
European Journal of Neuroscience (2018) Vol. 50, Iss. 3, pp. 2562-2573
Open Access | Times Cited: 86
The cancer-immune dialogue in the context of stress
Yuting Ma, Guido Kroemer
Nature reviews. Immunology (2023) Vol. 24, Iss. 4, pp. 264-281
Closed Access | Times Cited: 34
Neuro-Immune Mechanisms Regulating Social Behavior: Dopamine as Mediator?
Ashley M. Kopec, Caroline J. Smith, Staci D. Bilbo
Trends in Neurosciences (2019) Vol. 42, Iss. 5, pp. 337-348
Open Access | Times Cited: 62
Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders
Béla Kiss, I. Laszlovszky, Balázs Krámos, et al.
Biomolecules (2021) Vol. 11, Iss. 1, pp. 104-104
Open Access | Times Cited: 51
Immunological Dysfunction in Tourette Syndrome and Related Disorders
Chia‐Jui Hsu, Lee‐Chin Wong, Wang‐Tso Lee
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 853-853
Open Access | Times Cited: 50
The Multifarious Applications of Copper Nanoclusters in Biosensing and Bioimaging and Their Translational Role in Early Disease Detection
Kumar Babu Busi, Mathangi Palanivel, Krishna Ghosh, et al.
Nanomaterials (2022) Vol. 12, Iss. 3, pp. 301-301
Open Access | Times Cited: 35
The role of the brain renin-angiotensin system in Parkinson´s disease
José L. Labandeira‐García, Carmen M. Labandeira, María J. Guerra, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Dopamine regulates cytokine secretion during innate and adaptive immune responses
Masaaki Kawano, Rie Takagi, Kikue Saika, et al.
International Immunology (2018) Vol. 30, Iss. 12, pp. 591-606
Closed Access | Times Cited: 54
α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes
Ren‐Hong Du, Yan Zhou, Meiling Xia, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 48
Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform
George Mpekoulis, Efseveia Frakolaki, Styliani Τaka, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0253458-e0253458
Open Access | Times Cited: 33
Dopamine, a co-regulatory component, bridges the central nervous system and the immune system
Mingan Li, Lin Zhou, Xiaohui Sun, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112458-112458
Open Access | Times Cited: 33
Treatment-resistant depression: molecular mechanisms and management
Mayanja Kajumba, Angelina Kakooza‐Mwesige, Noeline Nakasujja, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 6
Potential Roles of Peripheral Dopamine in Tumor Immunity
Xiang Zhang, Qiaofei Liu, Quan Liao, et al.
Journal of Cancer (2017) Vol. 8, Iss. 15, pp. 2966-2973
Open Access | Times Cited: 47
Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics
Samantha Álvarez-Herrera, Raúl Escamilla, Óscar Medina‐Contreras, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 37
Inflammatory Mechanisms in Parkinson’s Disease: From Pathogenesis to Targeted Therapies
S.Y. Lee, Nathanael J. Yates, Susannah J. Tye
The Neuroscientist (2021) Vol. 28, Iss. 5, pp. 485-506
Closed Access | Times Cited: 28
Targeting DRD2 by the antipsychotic drug, penfluridol, retards growth of renal cell carcinoma via inducing stemness inhibition and autophagy-mediated apoptosis
Min‐Che Tung, Yung‐Wei Lin, Wei‐Jiunn Lee, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 21
Secreted immune metabolites that mediate immune cell communication and function
Baihao Zhang, Alexis Vogelzang, Sidonia Fagarasan
Trends in Immunology (2022) Vol. 43, Iss. 12, pp. 990-1005
Open Access | Times Cited: 20
Who Knew? Dopamine Transporter Activity Is Critical in Innate and Adaptive Immune Responses
Adithya Gopinath, Phillip Mackie, Leah Phan, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 269-269
Open Access | Times Cited: 12
Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia
Samantha Álvarez-Herrera, Mauricio Rosel-Vales, Gilberto Pérez‐Sánchez, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 167-167
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top